GENE ONLINE|News &
Opinion
Blog

Rajaneesh K. Gopinath

WRITTEN BY Rajaneesh K. Gopinath

Primed to Surpass CRISPR: Prime Medicine Emerges Out of Stealth with $315 Million in Funding
2021-07-15
In Quest For Scalability in Cell Therapy Manufacturing, Cellares Partners with Poseida
2021-07-14
WHO Recommends the Use of Sanofi’s and Roche’s Rheumatoid Arthritis Drugs to Cut COVID-19 Deaths
2021-07-12
FDA Okays Bayer’s Kidney Disease Drug, Kicking Off Market Rivalry Against Established SGLT-2 Inhibitors
2021-07-12
Sequanta Partners with Surging Single-Cell Genomics Startup to Serve Multi-Omics Market in China
2021-07-11
Eli Lilly and Boehringer Ingelheim’s Jardiance Shows Encouraging Phase 3 HFpEF Data
2021-07-07
FDA Approves Jazz Pharma’s Rylaze for Treating Common Leukemia in Children
2021-07-04
FoundationOne CDx Okayed as Companion Diagnostic for Takeda’s Lung Cancer Drug
2021-07-04
AbbVie to Acquire TeneoOne and Its Lead Multiple Myeloma Drug
2021-06-27
A New Era Begins! Intellia Reports First Clinical Proof for Direct CRISPR Genome Editing in Humans
2021-06-27
FDA Grants Breakthrough Status to Two Experimental Alzheimer’s Drugs While Pushback Over Aduhelm’s Approval Still Rages On
2021-06-25
Blackstone Pumps $250 Million in CAR-T Startup, Betting on Intellia’s and Cellex’s Technologies
2021-06-23
FDA Greenlights Blueprint Medicines’ Ayvakit for Rare Disease Treatment
2021-06-21
BMS Initiates Global Partnership to Advance Eisai’s First ADC to Market
2021-06-20
Monoclonal Antibodies for COVID-19: AstraZeneca and Regeneron’s Therapies Endure Contrasting Fortunes
2021-06-16
1 4 5 6 7 8 20
Scroll to Top